Showing posts with label Blockbuster Drugs. Show all posts
Showing posts with label Blockbuster Drugs. Show all posts

Monday, 12 January 2009

Brand Revitalisation

Given that the global pharma industry is going through a period of significant upheaval, I thought its appropriate to provide a definition of brand revitalisation. Quite a few blockbuster brands are in a period where their marketers try and infuse a bit of extra life into their pedigree creations - to garner some extra revenues and to flog a few extra miles out of a dead / dying horse :)

Here is an excellent summary, courtesy The Value Engineers (http://www.thevalueengineers.com/tve/uploads/40/40_Document_1.pdf)

Brand revitalisation: the business of taking a brand that is losing consumer
resonance and relevance, and re-energising it via a compelling new proposition or
idea.

Key points:

1. Its big business – as the pace of change and weight of competition threatens
longstanding brands with marginisation.

2. It’s generally a cheaper and less risky process than building new brands from
scratch.

3. It can be the first step in a program of “brand turbo charging” – the elevation of a
brand from product–brand to cross–category power-brand status.

4. It’s a complex process involving up to 5 stages: problem diagnosis, startpoint
definition, development option creation, proposition selection/ refinement and
marketplace execution – and then there’s product innovation…

5. Insight is a sine qua non - to get to the heart of the brand and what it stands for,
and to identify new market-led opportunities that the brand can tap into.

6. “Connectivity” is crucial – even when a brand re-orientates to meet a new need,
there should be a line of connection back to the original brand construct.

7. Target markets change with the revitalisation program – this can be either
“modification” or “clean break”.

8. Brand architecture – the structure of brand/sub-brands/products – will probably
require reorganising.

9. Build business assessments into the process – new proposition concepts may
look exciting, but how wide is its appeal and how much volume will it generate?

10. Early steps in market executions are critical – mistakes at a later stage can be
tolerated, but at an early stage they can prove terminal.

- oRiOn